By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Curis, Inc. 

61 Moulton Street

Cambridge  Massachusetts  02138  U.S.A.
Phone: 617-876-0086 Fax: 617-876-0866



Company News
Curis (CRIS) Presents Early Clinical Pharmacokinetic And Biomarker Data From CA-170’s Phase I Trial At The SITC 2016 Conference 11/10/2016 8:16:36 AM
Curis (CRIS) Announces Oral Presentation Of Clinical Data Update From The Phase I Study Of CUDC-907 At The 21st Congress Of The European Hematology Association 6/8/2016 7:55:51 AM
Curis (CRIS) To Present At The Jefferies Healthcare Conferencea 6/2/2016 10:25:39 AM
Curis (CRIS) Announces FDA Acceptance Of Investigational New Drug Application For CA-170, The First Orally Available Small Molecule To Target And Inhibit Immune Checkpoints 6/1/2016 8:06:24 AM
Curis (CRIS) To Release First Quarter 2016 Financial Results And Hold Conference Call On May 9, 2016 5/2/2016 7:48:41 AM
Curis (CRIS) And Aurigene Discovery Technologies Limited Present Preclinical Data From Multiple Programs At AACR Annual Meeting 4/20/2016 9:48:48 AM
Curis (CRIS) Announces Presentation Of Preclinical Data From CUDC-907, CA-170 And PD-L1/TIM-3 Antagonist And CA-4948 Programs At AACR Annual Meeting 4/11/2016 8:17:55 AM
Curis (CRIS) Announces Publication Of CUDC-907 Phase I Clinical Trial Data In Lancet Oncology 4/4/2016 8:33:59 AM
Massachusetts' Curis (CRIS) Names New CFO, CAO 3/30/2016 6:12:32 AM
Curis, Inc. (CRIS) To Present At The 28th Annual Roth Conference 3/8/2016 8:15:08 AM